STOCK TITAN

Repligen (NASDAQ: RGEN) Eddleman trusts report passive stake under 5%

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Repligen Corporation’s common stock ownership has been updated by several Eddleman-related trusts in an amended Schedule 13G.

The Roy T. Eddleman Living Trust reports beneficial ownership of 2,705,689 shares of Repligen common stock, representing 4.81% of the class. The Roy T. Eddleman Charitable Remainder Trust #1 reports beneficial ownership of 29,604 shares, representing 0.001% of the class, while Charitable Remainder Trust #2 reports no shares. Co‑trustees Geoffrey Paul, Nereyda Rubio and Anis Garci share voting and investment power over a total of 2,735,293 shares. The filing states these securities are held on a passive basis and not for the purpose of changing or influencing control of Repligen.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Roy T. Eddleman Living Trust
Signature:/s/ Nereyda Rubio
Name/Title:Nereyda Rubio/Co-Trustee
Date:02/13/2026
Signature:/s/ Anis Garci
Name/Title:Anis Garci/Co-Trustee
Date:02/13/2026
Signature:/s/ Geoffrey Paul
Name/Title:Geoffrey Paul/Co-Trustee
Date:02/13/2026
Roy T. Eddleman Charitable Remainder Trust #1
Signature:/s/ Nereyda Rubio
Name/Title:Nereyda Rubio/Co-Trustee
Date:02/13/2026
Signature:/s/ Anis Garci
Name/Title:Anis Garci/Co-Trustee
Date:02/13/2026
Signature:/s/ Geoffrey Paul
Name/Title:Geoffrey Paul/Co-Trustee
Date:02/13/2026
Roy T. Eddleman Charitable Remainder Trust #2
Signature:/s/ Nereyda Rubio
Name/Title:Nereyda Rubio/Co-Trustee
Date:02/13/2026
Signature:/s/ Anis Garci
Name/Title:Anis Garci/Co-Trustee
Date:02/13/2026
Signature:/s/ Geoffrey Paul
Name/Title:Geoffrey Paul/Co-Trustee
Date:02/13/2026

FAQ

What does the amended Schedule 13G/A report for Repligen (RGEN)?

The amended Schedule 13G/A reports updated ownership of Repligen by Eddleman-related trusts. The Living Trust holds 2,705,689 shares and Charitable Remainder Trust #1 holds 29,604 shares of common stock, with co‑trustees sharing voting and investment power over 2,735,293 shares in total.

How many Repligen (RGEN) shares does the Roy T. Eddleman Living Trust own?

The Roy T. Eddleman Living Trust reports beneficial ownership of 2,705,689 Repligen common shares. This stake represents 4.81% of the company’s outstanding common stock, based on 56,290,749 shares outstanding as of October 30, 2025, as cited in the ownership calculation.

What percentage of Repligen (RGEN) does each Eddleman trust hold?

The Roy T. Eddleman Living Trust holds 4.81% of Repligen’s common stock. The Roy T. Eddleman Charitable Remainder Trust #1 holds 29,604 shares, representing 0.001% of the class, while Charitable Remainder Trust #2 reports beneficial ownership of zero Repligen common shares in this filing.

Who controls voting and investment decisions for the Repligen (RGEN) shares in these trusts?

Co‑trustees Geoffrey Paul, Nereyda Rubio and Anis Garci control voting and investment decisions. As co‑trustees of each reporting person, they share voting and dispositive power over 2,735,293 Repligen shares and may be deemed to have shared beneficial ownership subject to their pecuniary interests.

Are the Eddleman trusts seeking to influence control of Repligen (RGEN)?

The filing explicitly certifies the shares are not held to change or influence control of Repligen. It states the securities were not acquired and are not held for control purposes, other than activities solely connected with a nomination under Rule 240.14a‑11, indicating a passive investment intent.

Why does the Schedule 13G/A note ownership of 5 percent or less for Repligen (RGEN)?

The ownership section states "Ownership of 5 percent or less of a class," indicating the reporting persons now hold 5% or less of Repligen’s common stock. The detailed cover pages show the Living Trust at 4.81% and Charitable Remainder Trust #1 at 0.001%, with no shares in Trust #2.
Repligen

NASDAQ:RGEN

RGEN Rankings

RGEN Latest News

RGEN Latest SEC Filings

RGEN Stock Data

7.47B
52.45M
6.38%
99.2%
6.44%
Medical Instruments & Supplies
Biological Products, (no Diagnostic Substances)
Link
United States
WALTHAM